Value | Commercial | Access

Apersy provide flexible support to bring the commercial point of view to your development programme

Extensive experience, unique expertise

Seeing pricing and market access from all sides: experience working for different stakeholders

  • CROs
  • Investment management
  • NGOs/think tanks
  • Big pharma
  • Biotech
  • Start-ups & techtransfer

However novel your product or particular your situation, weird and wonderful is our bread and butter.

  • Digital medical devices / healthcare AI
  • Connected diagnostics
  • Microbiome products
  • Combination products
  • Advance therapies
  • Orphan drugs

Focus expertise on European markets

Healthcare systems, payers and insurance, reimbursement processes and HTA requirements, agencies, …

Collaborating differently

Being part of your team, intermediary, mentor, expert;

Finding the perfect development experts and partners for your needs;

Network within the healthcare and product development space.

Henrike Granzow, MSc

Market Access, pricing and reimbursement expert, Health Economist, mentor and trainer for health tech innovation, emerging & disruptive technologies.

For over 13 years I have been working within Life Science strategy consultancies, Biotech & MedTech investment management, clinical research organisations and health policy. My working approach focuses on value creation & takes a holistic view on asset & evidence strategy .

Special topics: Digital healthcare solutions, product strategy, multi-indication launches, orphan disease, ATMPs, due diligence, forecasting and portfolio advisory, diagnostics 

Working with Apersy


Your science meets commercial expertise


Connections, management and partnerships


Frameworks, thought processing and training that foster understanding